Molecular Relapse
Molecular Relapse is a type of relapse in oncology defined by the reappearance of disease-specific molecular markers in the absence of overt clinical or radiographic evidence of disease recurrence.
238
Publications
16K
Citations
2.5K
Authors
853
Institutions
Publications per year
2017–2026
97
Variants
Molecular Recurrence
Parents
238
Subtypes of Breast Cancer Show Preferential Site of Relapse
Marcel Smid, Yixin Wang, Yi Zhang et al. · Cancer Research · 2008 · 837 citations
Medicine, Cancer Biology, Oncology +16
Molecular Minimal Residual Disease in Acute Myeloid Leukemia
Mojca Jongen‐Lavrencic, Tim Grob, Diana Hanekamp et al. · New England Journal of Medicine · 2018 · 781 citations · Full text
Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis
Eric E. Gardner, Benjamin H. Lok, Valentina E. Schneeberger et al. · Cancer Cell · 2017 · 535 citations · Full text
Medicine, Cancer Biology, Oncology +14
1–5 of 238
2.5K
8
h-index
8
h-index
7
h-index
6
h-index
6
h-index
1–5 of 2.5K
853
Heidelberg University
Heidelberg, Germany
16 h-index
81 publications
4K citations
Inserm
Paris, France
14 h-index
76 publications
6.5K citations

Aarhus University Hospital
Aarhus, Denmark
10 h-index
44 publications
4.1K citations
Hôpital Saint-Louis
Paris, France
10 h-index
34 publications
1.6K citations

University Hospital Heidelberg
Heidelberg, Germany
9 h-index
34 publications
1.8K citations
German Cancer Research Center
Heidelberg, Germany
9 h-index
35 publications
1.5K citations
Universität Hamburg
Hamburg, Germany
9 h-index
28 publications
779 citations
University Medical Center Hamburg-Eppendorf
Hamburg, Germany
8 h-index
27 publications
752 citations
1–8 of 853
17 publications · 1.4K citations
15
h-index
BJH · 15 publications · 755 citations
13
h-index
10 publications · 1.1K citations
10
h-index
9 publications · 731 citations
9
h-index
8 publications · 282 citations
8
h-index
1–5